New app aims to help cancer patients spot medication dangers at home

NCT ID NCT07291414

Recruiting now Knowledge-focused Sponsor: University of Michigan Rogel Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether an online self-monitoring platform helps patients with lung, colorectal, breast, or prostate cancer track medication safety events and concerns while taking oral anticancer drugs at home. Eighty adult patients currently on active cancer treatment will use the platform to log symptoms and issues, and researchers will measure usability, engagement, and health outcomes like emergency visits. The goal is to see if this tool can empower patients to become more vigilant about their medication safety.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: self-monitoring platform
What this could lead to: If successful, this could provide a simple tool for cancer patients to better track medication side effects and communicate with their care team, potentially reducing emergency visits.
What could go wrong: This is a small, early-stage study focused on usability and feasibility, not on proving health outcomes. The platform may not be widely adopted or show clear benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast carcinoma breast neoplasm cancer colorectal carcinoma colorectal neoplasm lung carcinoma lung neoplasm prostate cancer prostate carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CARCINOMA COLORECTAL CARCINOMA LUNG CARCINOMA MALIGNANT SOLID NEOPLASM PROSTATE CARCINOMA

Contacts and locations

Locations

University of Michigan Comprehensive Cancer Center
RECRUITING

Ann Arbor, Michigan, 48109, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.